版本:
中国

BRIEF-Akcea initiates phase 2 study of Akcea-APO(a)-l RX in patients with high LP(a) and cardiovascular disease

March 30 Ionis Pharmaceuticals Inc

* Akcea initiates phase 2 study of Akcea-APO(a)-l RX in patients with high LP(a) and cardiovascular disease

* Akcea Therapeutics - plans to report top-line data from this study in middle of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐